This new tool, known as minimal, versatile genetic perturbation technology (mvGPT), combines the powers of gene editing, ...
BizTimes Media’s 24th annual Economic Trends event on Thursday featured insights and predictions from an economist, local business leaders and an academic ...
The HAELO trial will assess the therapy’s safety and efficacy in 60 adult subjects with Type I or Type II HAE.
Hosted on MSN23h
Vertex Down 13% in 6 Months: Buy, Sell or Hold the Stock?The stock of Vertex Pharmaceuticals Incorporated VRTX has declined almost 13% in the past six months. A key reason for the stock price decline was unimpressive data from a phase II study on its key ...
Functional genomics can help deconvolute the link between genotype and phenotype in disease, revealing new drug targets and ...
There are 20 cell and gene therapies on Europe's market versus 43 in the U.S. Find out more about this ecosystem.
Children's Mercy Kansas City has achieved a significant advancement toward the treatment of rare genetic diseases through the ...
A team of researchers from NUS has developed a novel method to enhance the precision of cancer treatment using gold ...
After a delayed approval, treosulfan’s manufacturer is hopeful the alkylating agent will become the new gold standard in the United States.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback